Integrated Analysis of HER2 Copy Number by Cytogenomic Microarray in Breast Cancers With Nonclassical In Situ Hybridization Results-Reference-Cited by-同舟云学术

Integrated Analysis of HER2 Copy Number by Cytogenomic Microarray in Breast Cancers With Nonclassical In Situ Hybridization Results

Published:2018-01-29 Issue:2 Volume:149 Page:135-147
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Haskell Gloria T,Liu Yajuan J,Chen Hui,Chen Beiyun,Meyer Reid G,Yuhas Jason A,Geiersbach Katherine B

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/149/2/135/23688636/aqx143.pdf

Reference14 articles.

1. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J Clin Oncol,2013

2. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;Arch Pathol Lab Med,2014

3. Change in pattern of HER2 fluorescent in situ hybridization (FISH) results in breast cancers submitted for FISH testing: experience of a reference laboratory using US Food and Drug Administration criteria and American Society of Clinical Oncology and College of American Pathologists guidelines;Shah;J Clin Oncol,2016

4. HER2 gene amplification testing by fluorescent in situ hybridization (FISH): comparison of the ASCO-College of American Pathologists guidelines with FISH scores used for enrollment in breast cancer international research group clinical trials;Press;J Clin Oncol,2016

5. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer;Wolff;Arch Pathol Lab Med,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?;Clinical Breast Cancer;2023-06

2. Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations;Modern Pathology;2022-10

3. HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines;Breast Cancer Research and Treatment;2021-04-03